Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-31

Clinical Trial Update: Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating muscadine grape extract in men with recurrent prostate cancer on androgen deprivation therapy has completed and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Muscadine Grape Extract

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2026-03-31